Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Aesica Pharmaceuticals GmbH
FDA Inspection
•Aesica Pharmaceuticals GmbH•December 2, 2016

Aesica Pharmaceuticals GmbH – FDA Inspection, Dec 2, 2016

Record Details

This FDA Inspection record concerns Aesica Pharmaceuticals GmbH, with an inspection on December 2, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Aesica Pharmaceuticals GmbH
Inspection Date
December 2, 2016
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Toyin B. Oladimeji (Company Rep)
View Company Profile

ID · 3df675b2-3eea-44d0-834f-97f0db529daa

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
994783
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 211.111Establishment of time limitations
  2. 21 CFR 211.113(a)Procedures for non-sterile drug products
  3. 21 CFR 211.160(a)Deviations from laboratory control requirements
  4. 21 CFR 211.160(b)Scientifically sound laboratory controls
  5. 21 CFR 211.160(b)(3)Drug product sample
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.194(a)Complete test data included in records
  8. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  9. 21 CFR 211.67(b)Written procedures not established/followed
  10. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Aesica Pharmaceuticals GmbH

4
DateClassificationOfficeProject area
August 31, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 30, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 20, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 8, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Aesica Pharmaceuticals GmbH
  • FDA Inspection 1277716 - 2023-08-31
  • FDA Inspection 1105950 - 2019-08-30
  • FDA Inspection 887354 - 2014-06-20
  • FDA Inspection 759166 - 2011-11-08

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aesica Pharmaceuticals GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.